(Louis) Amplify ELA, Unit 6A, Dahl & Narrative, Writing Journal
by American Printing House for the Blind
Last verified May 24, 2026 · classified May 14, 2026
What it is
Summary
AI-generated from vendor-published content · May 14, 2026
This is a large-print writing journal designed to accompany Unit 6A of the Amplify ELA curriculum, which focuses on Roald Dahl and narrative writing. It's intended for students with low vision who are accessing the same grade-level ELA content as their sighted peers but need materials formatted for visual accessibility. What you're getting is a single consumable journal — a curriculum component, not a standalone product — so it works alongside the broader Amplify ELA instructional sequence and any other adapted materials for that unit. Federal Quota funds are available for eligible students, which is the primary funding route for blind and visually impaired students in U.S. schools.
Quick Facts Catalog facts · auto-generated
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
Distribute to the student alongside the corresponding Amplify ELA Unit 6A instruction — no setup required. - With professional help
A teacher of the visually impaired (TVI) or special education coordinator should confirm this matches the student's current curriculum unit and that the large-print format meets the student's visual needs before ordering.
Getting it
Many states lend devices like this for free trial periods — find your state's AT lending program.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified May 24, 2026.
Classification & description AI-generated from vendor-published content on May 14, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.